145 related articles for article (PubMed ID: 16140790)
1. Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.
Norbeck O; Isa A; Pöhlmann C; Broliden K; Kasprowicz V; Bowness P; Klenerman P; Tolfvenstam T
J Virol; 2005 Sep; 79(18):12117-21. PubMed ID: 16140790
[TBL] [Abstract][Full Text] [Related]
2. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
3. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
Corcoran A; Crowley B; Dewhurst C; Pizer BL; Doyle S
J Med Virol; 2006 Jan; 78(1):125-8. PubMed ID: 16299723
[TBL] [Abstract][Full Text] [Related]
4. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
Franssila R; Hedman K
Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862
[TBL] [Abstract][Full Text] [Related]
5. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Durkin HG; Smith-Norowitz TA
Hum Immunol; 2005 Oct; 66(10):1029-38. PubMed ID: 16386644
[TBL] [Abstract][Full Text] [Related]
6. T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19.
Franssila R; Hokynar K; Hedman K
J Infect Dis; 2001 Mar; 183(5):805-9. PubMed ID: 11181158
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
8. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
9. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
Corcoran A; Mahon BP; Doyle S
J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524
[TBL] [Abstract][Full Text] [Related]
10. Slow clearance of human parvovirus B19 viremia following acute infection.
Lindblom A; Isa A; Norbeck O; Wolf S; Johansson B; Broliden K; Tolfvenstam T
Clin Infect Dis; 2005 Oct; 41(8):1201-3. PubMed ID: 16163641
[TBL] [Abstract][Full Text] [Related]
11. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?
Mitchell LA
J Med Virol; 2002 Jun; 67(2):267-74. PubMed ID: 11992589
[TBL] [Abstract][Full Text] [Related]
13. Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
Tolfvenstam T; Lundqvist A; Levi M; Wahren B; Broliden K
Vaccine; 2000 Nov; 19(7-8):758-63. PubMed ID: 11115697
[TBL] [Abstract][Full Text] [Related]
14. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen.
Venturoli S; Gallinella G; Manaresi E; Gentilomi G; Musiani M; Zerbini M
J Infect Dis; 1998 Dec; 178(6):1826-9. PubMed ID: 9815244
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
16. Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice.
Mori K; Yoshida K; Ishii K; Morohoshi K; Nakagawa Y; Hoshikawa S; Ozaki H; Takahashi Y; Ito S
Autoimmunity; 2011 Sep; 44(6):483-9. PubMed ID: 21332425
[TBL] [Abstract][Full Text] [Related]
17. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.
Kasprowicz V; Isa A; Tolfvenstam T; Jeffery K; Bowness P; Klenerman P
J Virol; 2006 Nov; 80(22):11209-17. PubMed ID: 16943301
[TBL] [Abstract][Full Text] [Related]
18. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.
Gilbert L; Toivola J; White D; Ihalainen T; Smith W; Lindholm L; Vuento M; Oker-Blom C
Biochem Biophys Res Commun; 2005 Jun; 331(2):527-35. PubMed ID: 15850791
[TBL] [Abstract][Full Text] [Related]
19. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
